Home » Topics » Disease categories and therapies » Immune

Immune
RSS

StressGen's protein fusion vaccines elicit potent immune response without additional adjuvants

Dec. 7, 1998

Astra patents new pyrazolopyrimidinedione immunosuppressants

Dec. 4, 1998

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

Dec. 3, 1998

CPMP issues positive opinion for E.U. approval of Zenapax

Dec. 2, 1998

U.S. patent issued for Maxim's MaxVax technology

Dec. 2, 1998

Abbott purchases additional La Jolla stock

Dec. 1, 1998

OraVax files IND for colitis vaccine

Nov. 30, 1998

North American Vaccine continues product launch of Certiva in U.S.

Nov. 26, 1998

Positive clinical data supports Siga's unique vaccine delivery system

Nov. 25, 1998

Chiron reports phase II results of novel Meningococcus C vaccine trial

Nov. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...